Myasthénie
The serious myasthénie or myasthénie ( MG , in Latin myasthenia climbed = " serious weakness musculaire") is a Maladie neuromusculaire by attack of the neuro-muscular transmission involving a fluctuating weakness and a fatigability. It is one of the autoimmune diseases most known and the pathogenetic Antigène S and mechanisms were indeed elucidated. The weakness is due to the circulating Anticorps which block the receiving S of the Acétylcholine to the post-synaptic Jonction neuromusculaire, thus inhibiting the stimulating effect on the Neurotransmetteur, the acetylcholine. The myasthénie is treated by Immunosuppression and inhibiting of the cholinestérase.
History
Clinical demonstrations
Classically, fatigability makes the contraction muscular each less intense time.The clinical demonstrations can include:
- a Diplopia (vision doubles and/or deformed)
- a Ptosis (falls of one or the 2 eyelids)
- a weakness of the muscles:
- facial
- respiratory
- proximaux
The attack can remain limited to the ocular muscles, then, a Thymome is frequently associated.
Diagnosis
- Clinical examination:
-
pharmacological Tests
- electric Examinations (Electromyogram or EMG)
-
biological Examination:
-
to draw up a complete assessment and because of the frequent autoimmune ground within the framework of the autoimmune diseases, one can also seek: anti-thyroid antibodies (TSH) the smooth antibodies anti-muscles and antinuclear antibodies (ACAN).
-
muscular biopsy:
-
Search for a thymome
-
Search for an associated autoimmune affection
Classification of the various stages
SCALE Of OSSERMAN MODIFIEE
- Stage 1: myasthénie ocular pure
- Stage 2: myasthénie generalized of average gravity with usually ocular signs but not of bulbar or respiratory sign
- Stage 3: myasthénie generalized of average gravity with usually ocular signs and bulbar signs but without respiratory sign
- Stage 4: myasthénie generalized rather severe with usually ocular, bulbar signs and moderate respiratory attack
- Stage 5: myasthénie generalized severe with respiratory attack engraves
Treatment of the myasthénie
The myasthénie can be treated by inhibiting drugs of the cholinestérases like the mestinon or the mythelase. These drugs prevent the degradation of acetylcholine. Another solution in the event of thymome is the thymectomy. The other therapeutic ones, immunomodulateurs are sometimes used: intravenous general-purpose immunoglobulin perfusions even of the Corticoids more or less associated with L Imurel.
External bonds
- ''' FRIENDLY - Association of Myasthéniques '''; Isolated and Interdependent. /French-speaking Myasthenie.com/Association dedicated to the patients of Myasthénie and to their families. Site, forum, meetings, seminars…
- HonSelect
- CHU of Rouen
Sources
- muscular Myasthénie AFM
- Dystrophy Canada
- Online Mendelian Inheritance in Man, OMIM (TM). Johns Hopkins University, Baltimore
| Random links: | Duality (mathematics) | The Great Jump | Friedrich Wilhem von Bismarck | Bahige Tabbara | Netlib | Carsten_Niebuhr |